WITHDRAWN: Higher appendicular skeletal muscle mass percentage is an independent protective factor for non-alcoholic steatohepatitis and significant fibrosis in male with NAFLD
Authors:
- 4 September 2020
- journal article
- withdrawal
- Published by Elsevier in Gastroenterología y Hepatología
Abstract
No abstract availableThis publication has 27 references indexed in Scilit:
- New trends on obesity and NAFLD in AsiaJournal of Hepatology, 2017
- Sarcopenia is an independent risk factor for non-alcoholic steatohepatitis and significant fibrosisJournal of Hepatology, 2017
- Sarcopenia is associated with severe liver fibrosis in patients with non-alcoholic fatty liver diseaseAlimentary Pharmacology & Therapeutics, 2016
- The multiple-hit pathogenesis of non-alcoholic fatty liver disease (NAFLD)Metabolism, 2016
- The globalization of nonalcoholic fatty liver disease: Prevalence and impact on world healthHepatology, 2016
- Sarcopenia is associated with significant liver fibrosis independently of obesity and insulin resistance in nonalcoholic fatty liver disease: Nationwide surveys (KNHANES 2008‐2011)Hepatology, 2015
- Epidemiology and Natural History of Nonalcoholic Fatty Liver DiseaseSeminars in Liver Disease, 2015
- Liver Fibrosis, but No Other Histologic Features, Is Associated With Long-term Outcomes of Patients With Nonalcoholic Fatty Liver DiseaseGastroenterology, 2015
- Fibrosis Progression in Nonalcoholic Fatty Liver vs Nonalcoholic Steatohepatitis: A Systematic Review and Meta-analysis of Paired-Biopsy StudiesClinical Gastroenterology and Hepatology, 2015
- Fibrosis stage is the strongest predictor for disease‐specific mortality in NAFLD after up to 33 years of follow‐upHepatology, 2014